A comparison of D2 receptor specific binding in obese and normal‐weight individuals using PET with (N‐[11C]methyl)benperidol
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Previous PET imaging studies have demonstrated mixed findings regarding dopamine D2/D3 receptor availability in obese relative to nonobese humans. Nonspecific D2/D3 radioligands do not allow for separate estimation of D2 receptor (D2R) and D3 receptor (D3R) subtypes of the D2 receptor family, which may play different roles in behavior and are distributed differently throughout the brain. These radioligands are also displaceable by endogenous dopamine, confounding interpretation of differences in receptor availability with differing levels of dopamine release. The present study used PET imaging with the D2R‐selective radioligand (N‐[11 C] methyl)benperidol ([11 C]NMB), which is nondisplaceable by endogenous dopamine, to estimate D2R specific binding (BP ND) and its relationship to body mass index (BMI) and age in 15 normal‐weight (mean BMI = 22.6 kg/m 2) and 15 obese (mean BMI = 40.3 kg/m 2) men and women. Subjects with illnesses or taking medications that interfere with dopamine signaling were excluded. Striatal D2R BP ND was calculated using the Logan graphical method with cerebellum as a reference region. D2R BP ND estimates were higher in putamen and caudate relative to nucleus accumbens, but did not differ between normal‐weight and obese groups. BMI values did not correlate with D2R BP ND. Age was negatively correlated with putamen D2R BP ND in both groups. These results suggest that altered D2R specific binding is not involved in the pathogenesis of obesity per se and underscore the need for additional studies evaluating the relationship between D3R, dopamine reuptake, or endogenous dopamine release and human obesity. Synapse 67:748–756, 2013.. © 2013 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Faul, F., Erdfelder, E., Lang, A.-G., & Buchner, A. (2007) · Behavior Research Methods · doi:10.3758/bf03193146 · Cited by 65,971
Standards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
KESSLER, R. C., ADLER, L., AMES, M., DEMLER, O., FARAONE, S., HIRIPI, E., HOWES, M. J., JIN, R., SECNIK, K., SPENCER, T., et al. (2005) · Psychological Medicine · doi:10.1017/s0033291704002892 · Cited by 3,452 · cited 1×
“1, Kessler et al., 2005).”
The physiology, signaling, and pharmacology of dopamine receptors
Beaulieu, J.-M., & Gainetdinov, R. R. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.002642 · Cited by 2,763
Wang, G.-J., Volkow, N. D., Logan, J., Pappas, N. R., Wong, C. T., Zhu, W., Netusll, N., & Fowler, J. S. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03643-6 · Cited by 1,864 · cited 26×
“The power of our study to detect differences in D2R BPND estimates between normal-weight and obese groups as well as to detect correlations between D2R BPND estimates and BMI in the obese group was calculated based on results from previous studies of D2=D3 receptor availability (de Weijer et al., 2011; Dunn et al., 20…”
BackgroundMethodResultInfluentialVolkow, N. D., Fowler, J. S., Wang, G., Hitzemann, R., Logan, J., Schlyer, D. J., Dewey, S. L., & Wolf, A. P. (1993) · Synapse · doi:10.1002/syn.890140210 · Cited by 924
Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Ding, Y.-S., Sedler, M., Logan, J., Franceschi, D., Gatley, J., Hitzemann, R., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2015 · Cited by 916 · cited 2×
“reduced striatal D2=D3 dopamine receptor availability, as evaluated in vivo with PET imaging (Hietala et al., 1994; Volkow et al., 1993; Volkow et al., 2001; Wang et al., 1997).”
BackgroundMethodWidespread reward-system activation in obese women in response to pictures of high-calorie foods
Stoeckel, L. E., Weller, R. E., Cook, E. W., Twieg, D. B., Knowlton, R. C., & Cox, J. E. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.02.031 · Cited by 857 · cited 2×
“, visual images of high calorie food) in obese than in nonobese individuals (Stoeckel et al., 2008), but blunted striatal activation in response to consumption of a highly palatable food that was negatively correlated with BMI in obese individuals (Stice et al.”
BackgroundVolkow, N. D., Wang, G.-J., Telang, F., Fowler, J. S., Thanos, P. K., Logan, J., Alexoff, D., Ding, Y.-S., Wong, C., Ma, Y., et al. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.06.002 · Cited by 573
Weight Gain Is Associated with Reduced Striatal Response to Palatable Food
Stice, E., Yokum, S., Blum, K., & Bohon, C. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2105-10.2010 · Cited by 401 · cited 2×
“, 2008), but blunted striatal activation in response to consumption of a highly palatable food that was negatively correlated with BMI in obese individuals (Stice et al., 2010).”
BackgroundStriatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence
Hietala, J., West, C., Syvälahti, E., Någren, K., Lehikoinen, P., Sonninen, P., & Ruotsalainen, U. (1994) · Psychopharmacology · doi:10.1007/bf02245330 · Cited by 269
Lower striatal dopamine D2/3 receptor availability in obese compared with non-obese subjects
de Weijer, B. A., van de Giessen, E., van Amelsvoort, T. A., Boot, E., Braak, B., Janssen, I. M., van de Laar, A., Fliers, E., Serlie, M. J., & Booij, J. (2011) · EJNMMI Research · doi:10.1186/2191-219x-1-37 · Cited by 176 · cited 11×
“Finally, our normal-weight and obese participants were younger (normal-weight age range: 22.4–39.9 years; obese: 25.4–40.9 years) than in Wang et al. (2001) (range: 25–54 years), de Weijer et al. (2011) (range 5 20–60 years) and Dunn et al. (2012) (mean age 5 40 years, range not available).”
InfluentialDunn, J. P., Kessler, R. M., Feurer, I. D., Volkow, N. D., Patterson, B. W., Ansari, M. S., Li, R., Marks-Shulman, P., & Abumrad, N. N. (2012) · Diabetes Care · doi:10.2337/dc11-2250 · Cited by 148 · cited 18×
“The power of our study to detect differences in D2R BPND estimates between normal-weight and obese groups as well as to detect correlations between D2R BPND estimates and BMI in the obese group was calculated based on results from previous studies of D2=D3 receptor availability (de Weijer et al., 2011; Dunn et al., 20…”
BackgroundMethodResultInfluentialEffects of intravenous glucose on dopaminergic function in the human brain in vivo
Haltia, L. T., Rinne, J. O., Merisaari, H., Maguire, R. P., Savontaus, E., Helin, S., Någren, K., & Kaasinen, V. (2007) · Synapse · doi:10.1002/syn.20418 · Cited by 148 · cited 9×
“=D3 receptor availability in obesity have used [11C]raclopride (Haltia et al., 2007; Wang et al., 2001), [18F]fallypride (Dunn et al., 2012), and [123I]IBZM (de Weijer et al., 2011).”
BackgroundMethodInfluentialAmphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans
Riccardi, P., Li, R., Ansari, M. S., Zald, D., Park, S., Dawant, B., Anderson, S., Doop, M., Woodward, N., Schoenberg, E., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300916 · Cited by 134 · cited 4×
“Second, endogenous dopamine release decreases specific binding of [(11)C]raclopride, [(18)F]fallypride, or [(123)I]IBZM (Dewey et al., 1993; Laruelle et al., 1995; Riccardi et al., 2006), making these radioligands useful to measure endogenous dopamine release but confounding interpretation of D2=D3 receptor availabili…”
BackgroundInfluential
Cited by
Val-Laillet, D., Aarts, E., Weber, B., Ferrari, M., Quaresima, V., Stoeckel, L. E., Alonso-Alonso, M., Audette, M., Malbert, C. H., & Stice, E. (2015) · NeuroImage: Clinical · doi:10.1016/j.nicl.2015.03.016 · Cited by 442
Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and Future
Li, P., L. Snyder, G., & E. Vanover, K. (2016) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026616666160608084834 · Cited by 266
The role of reward circuitry and food addiction in the obesity epidemic: An update
Leigh, S.-J., & Morris, M. J. (2018) · Biological Psychology · doi:10.1016/j.biopsycho.2016.12.013 · Cited by 191
Neural vulnerability factors that increase risk for future weight gain
Stice, E., & Yokum, S. (2016) · Psychological Bulletin · doi:10.1037/bul0000044 · Cited by 179
“…striatal dopamine D2 receptor availability than lean humans (de Weijer et al., 2011; Haltia et al., 2007; Kessler et al., 2014; Volkow et al., 2008), though other studies have not replicated this finding (Eisenstein et al., 2013; Haltia et al., 2008; Karlsson et al., 2015; Steele et al., 2010).”
BackgroundBariatric surgery-induced weight loss causes remission of food addiction in extreme obesity
Pepino, M. Y., Stein, R. I., Eagon, J. C., & Klein, S. (2014) · Obesity · doi:10.1002/oby.20797 · Cited by 172
“Data from several (1,35,36), but not all (37), studies have demonstrated that obesity is associated with a reduction in brain dopaminergic receptor availability, which is an important component of the central reward mechanism (1) and is associated with substance addiction (2).”
BackgroundSelf-citation
Metadata
- Authors
- Eisenstein, S. A., Antenor‐Dorsey, J. A. V., Gredysa, D. M., Koller, J. M., Bihun, E. C., Ranck, S. A., ArbelÁez, A. M., Klein, S., Perlmutter, J. S., Moerlein, S. M., Black, K. J., & Hershey, T.
- Venue
- Synapse
- Publisher
- Wiley
- Published
- 2013-05-30
- Volume
- 67
- Issue
- 11
- Pages
- 748-756
- ISSN
- 0887-4476 (ISSN-L)
- 1098-2396
- OpenAlex
- W1489516196
- Cited by
- 87
- References
- 15
- FWCI
- 5.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.